Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach that is lost during drug treatment of gastric hyperacidity

• 收藏
• 分享

专利权人:

Probiotical S.p.A.

发明人:

MOGNA, Giovanni

申请号：

ES12722835

公开号：

ES2670968T3

申请日:

2012.04.18

申请国别(地区):

ES

年份:

2018

代理人:

摘要：

Pharmaceutical or food composition or a supplement comprising four strains selected from the group consisting of: 1. Lactobacillus pentosus LPS01 DSM 21980 2. Lactobacillus plantarum LP01 LMG P-21021 3. Lactobacillus plantarum LP02 LMG P-21020 4. Lactobacillus plantarum LP03 LMG P -21022 5. Lactobacillus plantarum LP04 LMG P-21023 6. Lactobacillus rhamnosus LR06 DSM 21981 7. Lactobacillus delbrueckii LDD 01 (MB386) DSMZ 20074 DSM 22106 8. Bifidobacterium longum B1975 DSM 24709 9. Bifidobacterium B70 DSM 24706 11. Bifidobacterium breve B7840 DSM 24708 12. Bifidobacterium longum PCB 133 DSM 24691 13. Bifidobacterium longum BL06 DSM 24689, which are capable of colonizing the stomach at a pH value between 4.5 and 5 and of producing bacteriocins and / or hydrogen peroxide, for use in the treatment of subjects taking drugs to reduce or treat gastric hyperacidity, in which said pharmaceutical composition or at imenticia or said complement is able to restore gastric barrier function.Composición farmacéutica o alimenticia o un complemento que comprende cuatro cepas seleccionadas del grupo que consiste en: 1. Lactobacillus pentosus LPS01 DSM 21980 2. Lactobacillus plantarum LP01 LMG P-21021 3. Lactobacillus plantarum LP02 LMG P-21020 4. Lactobacillus plantarum LP03 LMG P-21022 5. Lactobacillus plantarum LP04 LMG P-21023 6. Lactobacillus rhamnosus LR06 DSM 21981 7. Lactobacillus delbrueckii LDD 01 (MB386) DSMZ 20074 DSM 22106 8. Bifidobacterium longum B1975 DSM 24709 9. Bifidobacterium breve B2274 DSM 24707 10. Bifidobacterium breve B632 DSM 24706 11. Bifidobacterium breve B7840 DSM 24708 12. Bifidobacterium longum PCB 133 DSM 24691 13. Bifidobacterium longum BL06 DSM 24689, que son capaces de colonizar el estómago a un valor de pH comprendido entre 4,5 y 5 y de producir bacteriocinas y/o peróxido de hidrógeno, para su uso en el tratamiento de sujetos que toman fármacos para reducir o tratar hiperacidez gástrica, en la que dicha composición farmacéutica o alimenticia o dicho c

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/